Discover
RKDA
Arcadia Biosciences, Inc.
0.75
2 x 0.50
2 x 0.86
bid
ask
+
0.07
10.29%
2 @ 04:00 PM
0.69 -0.06 (8.41%)
| Ytd | -62.17% | |
| 1y | -83.09% |
0.63
day range
0.75
0.63
52 week range
6.71
| Open | 0.68 | Prev Close | 0.68 | Low | 0.63 | High | 0.75 | Mkt Cap | 1.54M |
| Vol | 154.20K | Avg Vol | 3.08M | EPS | -5.72 | P/E | N/A | Forward P/E | -4.76 |
| Beta | 1.27 | Short Ratio | 0.73 | Inst. Own | 4.70% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 03-19 | 50-d Avg | 0.96 | 200-d Avg | 2.31 | 1yr Est | 9.00 |
| Income Statement | |||
| Total Revenue | 1.10M | ||
| Revenues (USD) | 1.10M | ||
| Cost of Revenue | 700.00K | ||
| Gross Profit | 400.00K | ||
| Operating Expenses | 1.18M | ||
| Selling, General and Administrative Expense | 1.18M | ||
| Operating Income | -779.00K | ||
| Net Income | -4.38M | ||
| Net Income Common Stock | -4.38M | ||
| Net Income Common Stock (USD) | -4.38M | ||
| Consolidated Income | -4.38M | ||
| Earnings per Basic Share | -2.11 | ||
| Earnings per Basic Share (USD) | -2.11 | ||
| Earnings per Diluted Share | -2.11 | ||
| Earning Before Interest & Taxes (EBIT) | -4.38M | ||
| Earning Before Interest & Taxes (USD) | -4.38M | ||
| Weighted Average Shares | 2.08M | ||
| Weighted Average Shares Diluted | 2.08M | ||
| Balance Sheet | |||
| Cash and Equivalents | 954.00K | ||
| Cash and Equivalents (USD) | 954.00K | ||
| Investments | 2.77M | ||
| Investments Current | 2.77M | ||
| Trade and Non-Trade Receivables | 425.00K | ||
| Current Assets | 5.17M | ||
| Total Assets | 5.32M | ||
| Current Liabilities | 1.37M | ||
| Total Liabilities | 2.44M | ||
| Accumulated Retained Earnings (Deficit) | -285.60M | ||
| Shareholders Equity | 2.89M | ||
| Shareholders Equity (USD) | 2.89M | ||
| Assets Non-Current | 154.00K | ||
| Goodwill and Intangible Assets | 39.00K | ||
| Inventory | 840.00K | ||
| Liabilities Non-Current | 1.07M | ||
| Trade and Non-Trade Payables | 1.10M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 8.00K | ||
| Net Cash Flow from Financing | 1.79M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 695.00K | ||
| Issuance (Purchase) of Equity Shares | 1.79M | ||
| Net Cash Flow from Operations | -1.10M | ||
| Share Based Compensation | 15.00K | ||